Last reviewed · How we verify

Zinc Pyrithione — Competitive Intelligence Brief

Zinc Pyrithione (PYRITHIONE ZINC) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: pyrithione zinc. Area: Immunology.

marketed pyrithione zinc Potassium voltage-gated channel subfamily KQT member 2 Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Zinc Pyrithione (PYRITHIONE ZINC). Zinc Pyrithione works by inhibiting the activity of a specific potassium channel in the skin, which helps to reduce inflammation and prevent fungal growth.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Zinc Pyrithione TARGET PYRITHIONE ZINC marketed pyrithione zinc Potassium voltage-gated channel subfamily KQT member 2 1986-01-01
Multaq DRONEDARONE Sanofi marketed Antiarrhythmic [EPC] Potassium voltage-gated channel subfamily KQT member 2 2009-01-01
Katadolon FLUPIRTINE marketed flupirtine Serine hydroxymethyltransferase, mitochondrial, Potassium voltage-gated channel subfamily KQT member 2, Potassium voltage-gated channel subfamily KQT member 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (pyrithione zinc class)

  1. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Zinc Pyrithione — Competitive Intelligence Brief. https://druglandscape.com/ci/pyrithione-zinc. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: